Cargando…
Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model
Osteonecrosis is a common dose-limiting toxicity of glucocorticoids. Data from clinical trials suggest that other medications can increase the risk of glucocorticoid-induced osteonecrosis. Here we utilized a mouse model to study the effect of asparaginase treatment on dexamethasone-induced osteonecr...
Autores principales: | Liu, Chengcheng, Janke, Laura J., Kawedia, Jitesh D., Ramsey, Laura B., Cai, Xiangjun, Mattano, Leonard A., Boyd, Kelli L., Funk, Amy J., Relling, Mary V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788417/ https://www.ncbi.nlm.nih.gov/pubmed/26967741 http://dx.doi.org/10.1371/journal.pone.0151433 |
Ejemplares similares
-
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models
por: Karol, Seth E., et al.
Publicado: (2019) -
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice
por: Finch, Emily R., et al.
Publicado: (2020) -
Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII
por: Rathod, Sanjay, et al.
Publicado: (2019) -
Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity
por: Lane, Nancy E., et al.
Publicado: (2018) -
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia
por: Ramsey, Laura B., et al.
Publicado: (2015)